Albumin is one of the most commonly used assays in patients with IPF (7), and decreased serum albumin may reflect ongoing inflammation, malnutrition, or loss of albumin’s protective effects (inhibition of endothelial cell apoptosis, antioxidant effects, and reduced platelet aggregation) (8). Here, ALB is linked to idiopathic pulmonary fibrosis.